Oxford Finance closed a $50 million senior secured term loan with OncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of elite cancer responders.Proceeds from the transaction will be used for...
Read Story
February 16, 2022, 08:00 AM
|
Truist Securities announced that Lorenzo Paoletti has joined the firm as managing director to lead the Biotech investment banking team. Working together with Michael Allwin, who joined Truist Securities in August as managing director, these...
Read Story
September 24, 2021, 07:50 AM
|
Kane Biotech entered into an amended and restated credit agreement with Pivot Financial dated August 31, 2021.The Amended Credit Facility amends and restates the existing credit agreement with Pivot dated November 5, 2020, increasing the credit...
Read Story
September 03, 2021, 07:11 AM
|
Barclays announced the appointment of David Parrot as Managing Director and Head of Barclays’ US West Coast Biotech Banking franchise. Parrot will be based in Menlo Park, California, and will report to Rick Landgarten, Global Head of Healthcare &...
Read Story
December 11, 2018, 07:05 AM
|
William Blair, a global investment banking and asset management firm, announced the expansion of its global biopharmaceuticals franchise. John Sonnier, formerly an equity research analyst at William Blair, is joining the firm’s investment banking...
Read Story
July 21, 2017, 07:22 AM
|
CEOs in the life sciences business are more bullish about their own sector than their peers in other industries, and approximately 84 percent plan to hire in the next 12 months, according to KPMG LLP’s U.S. CEO Outlook 2016.All 38 life sciences CEOs...
Read Story
August 12, 2016, 07:49 AM
|
Healthcare Finance Group (HFG) provided a $15 million senior secured revolving line of credit to Premier Research. Premier Research is a leading contract research organization (CRO) providing clinical development services to biotech, pharmaceutical...
Read Story
March 13, 2013, 07:48 AM
|
American Capital announced today it has committed $212 million in the One Stop Buyout of Cambridge Major Laboratories (CML), a global provider of complex chemistry-based outsourcing services to the pharmaceutical and biotechnology industries. CML...
Read Story
December 28, 2012, 07:48 AM
|